Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
12/1999
12/22/1999EP0726893B1 Novel 4-piperidinyl substituted lactames as neurokinin 2 receptor antagonists for the treatment of asthma
12/22/1999CN1239474A Substituted pyridines and biphenyls as anti-hypercholesterinemic, anti-hyperlipoproteinemic and anti-hyperglycemic agents
12/22/1999CN1238990A Pigment marked protein composite and its preparing method
12/21/1999US6005109 Pyrazoles and pyrazolopyrimidines having CRF antagonistic activity
12/21/1999US6005103 Pyrone derivatives as protease inhibitors and antiviral agents
12/21/1999US6004989 Benzimidazole derivatives, their production and use
12/21/1999US6004965 Endothelin inhibitors; hypotensive agents; cardiovascular disorders
12/21/1999US6004963 Tumor necrosis factor release inhibitors; immunomodulators
12/21/1999US6004961 1,4-disubstituted piperazines
12/21/1999CA2060624C Benzimidazoles, pharmaceutical compositions containing these compounds and processes for preparing them
12/16/1999WO1999064422A1 Pyrido[2,3-b]indolizine derivatives and aza analogues thereof; crf1 specific ligands
12/16/1999WO1999064415A1 Sulfonylbenzene compounds as anti-inflammatory/analgesic agents
12/16/1999WO1999064413A1 Cinnamoyl distamycin analogous derivatives, process for their preparation, and their use as antitumor agents
12/16/1999WO1999064401A2 Imidazolyl derivatives and their use as somatostatin receptor ligands
12/16/1999WO1999064396A1 Substituted 1-aryl-3-benzylaminopyrrolidine: dopamine receptor subtype specific ligands
12/16/1999WO1999064395A1 Heterocyclic amide compounds as cell adhesion inhibitors
12/16/1999WO1999064055A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht4 receptors
12/16/1999WO1999064053A1 β3-ADRENERGIC RECEPTOR AGONISTS
12/16/1999WO1999064052A1 Novel leukotriene receptor antagonists and their uses
12/16/1999WO1999064043A1 Muscarinic receptor antagonists
12/16/1999WO1999064042A1 Novel therapeutic agents that modulate alpha-1a adrenergic receptors
12/16/1999WO1999064041A1 Multibinding agents that modulate nmda receptors
12/16/1999WO1999064038A1 Novel analgesic agents
12/16/1999WO1999064035A1 β2-ADRENERGIC RECEPTOR AGONISTS
12/16/1999WO1999064034A1 β2-ADRENERGIC RECEPTOR AGONISTS
12/16/1999WO1999064032A1 Combinatorial synthesis of multibinding libraries
12/16/1999WO1999064031A1 β2-ADRENERGIC RECEPTOR AGONISTS
12/16/1999WO1999064000A1 Novel therapeutic agents that modulate neurokinin receptors
12/16/1999WO1999063999A1 H1-histamine receptor antagonists
12/16/1999WO1999063996A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht2 receptors
12/16/1999WO1999063993A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the d1 receptors
12/16/1999WO1999063983A1 MULTIBINDING AGENTS THAT MODULATE PPARη AND RXR RECEPTORS
12/16/1999WO1999063944A2 Novel therapeutic agents that modulate estrogen receptors
12/16/1999WO1999063936A2 Novel therapeutic agents that modulate endothelin receptors
12/16/1999WO1999063933A2 Multivalent agonists, partial agonists and antagonists of the gaba receptors
12/16/1999WO1999063930A2 Novel angiotensin receptor modulators and their uses
12/16/1999WO1999043651A3 Inhibitors of phospholipase enzymes
12/16/1999CA2334945A1 Imidazolyl derivatives
12/16/1999CA2334671A1 Pyrido¬2,3-b|indolizine derivatives and aza analogues thereof; crf1 specific ligands
12/16/1999CA2321273A1 Novel analgesic agents
12/16/1999CA2321170A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the d1 receptors
12/16/1999CA2321152A1 Novel therapeutic agents that modulate endothelin receptors
12/16/1999CA2321120A1 .beta.3-adrenergic receptor agonists
12/16/1999CA2320926A1 Novel leukotriene receptor antagonists and their uses
12/16/1999CA2319756A1 Novel therapeutic agents that modulate alpha-1a adrenergic receptors
12/16/1999CA2319751A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht2 receptors
12/16/1999CA2319651A1 H1-histamine receptor antagonists
12/16/1999CA2319643A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht4 receptors
12/16/1999CA2319497A1 Novel therapeutic agents that modulate estrogen receptors
12/16/1999CA2319496A1 Multivalent agonists, partial agonists and antagonists of the gaba receptors
12/16/1999CA2319175A1 Multibinding agents that modulate nmda receptors
12/16/1999CA2319159A1 Novel therapeutic agents that modulate neurokinin receptors
12/16/1999CA2319068A1 Novel angiotensin receptor modulators and their uses
12/16/1999CA2318894A1 .beta.2-adrenergic receptor agonists
12/16/1999CA2318547A1 Combinatorial synthesis of multibinding libraries
12/16/1999CA2318286A1 Multibinding agents that modulate ppar.gamma. and rxr receptors
12/16/1999CA2318055A1 .beta.2-adrenergic receptor agonists
12/16/1999CA2315883A1 Muscarinic receptor antagonists
12/15/1999EP0963984A1 Heteroarylpiperidines and piperazines and their use as antipsychotics and analgetics
12/15/1999EP0664703B1 Methods of combating (pneumocystis carinii) pneumonia and compounds useful therefor
12/15/1999EP0610439B1 Pyrimidocycloalkanes as angiotensin ii antagonists
12/15/1999CN1238771A 2-imidazolinylaminoindole compounds useful as alpha-2 adrenoceptor agonists
12/15/1999CN1238689A Vitronectin receptor antagonists
12/15/1999CN1238218A Pigment marked polymerization antibody and preparation method thereof
12/14/1999US6002005 Certain 1-substituted aminomethyl imidazole and pyrrole derivatives: novel dopamine receptor subtype specific ligands
12/14/1999US6001835 Inhibitors of farnesyl-protein transferase
12/14/1999US6001834 [(4-heteroaryl-1-piperazinyl)alkoxy]-3,4-dihydro-1(2h)-naphthalenones and related compounds and their therapeutic utility
12/14/1999US6001833 Novel piperazine derivatives which are substituted in the 2-position by an indolylmethyl radical and in which the nitrogen in the 4-position of the piperazine ring forms part of a urea structure bearing a benzylaminoethyl substituent
12/14/1999US6001776 For the selective combating of monocotyledon and dicotyledon weeds in monocotyledon and dicotyledon crops, both pre-emergence and post-emergence
12/14/1999CA2081805C Process for the manufacture of substituted maleimides
12/14/1999CA2010636C Substituted pyrroles
12/09/1999WO1999062904A1 Sulfonic acid or sulfonylamino n-(heteroaralkyl)-azaheterocyclylamide compounds
12/09/1999WO1999062899A1 Tetrahydroindolone derivatives as gabaaalpha5 ligands for enhancing cognition
12/09/1999WO1999062888A1 Aza-heterocyclic compounds used to treat neurological disorders and hair loss
12/09/1999WO1999062887A1 Cyanoiminoquinoxaline derivatives
12/09/1999WO1999062885A1 Substituted 1-(4-aminophenyl)pyrazoles and their use as anti-inflammatory agents
12/09/1999WO1999062882A1 Substituted indolinones, the production thereof and their use as medicaments
12/09/1999WO1999062881A1 Aza-heterocyclic compounds used to treat neurological disorders and hair loss
12/09/1999WO1999062880A1 N-linked sulfonamides of n-heterocyclic carboxylic acids or carboxylic acid isosteres
12/09/1999WO1999062879A1 Ureas and carbamates of n-heterocyclic carboxylic acids and carboxylic acid isosteres
12/09/1999WO1999051591A3 N-aryloxyethyl-indoly-alkylamines for the treatment of depression
12/09/1999WO1999050244A9 Nitroxide free radical dual indicator agents
12/09/1999WO1999006397A3 Pyrrolidine-3-carboxylic acid derivatives and their use as endothelin antagonists
12/09/1999DE19924984A1 Compositions stabilized against degradation by light, oxidation and/or heat
12/09/1999DE19824922A1 Neue substituierte Indolinone, ihre Herstellung und ihre Verwendung als Arzneimittel New substituted indolinones, their preparation and their use as medicaments
12/09/1999CA2334002A1 N-linked sulphonamides of n-heterocyclic carboxylic acids or carboxylic acid isosteres
12/09/1999CA2333994A1 Sulfonic acid or sulfonylamino n-(heteroaralkyl)-azaheterocyclylamide compounds
12/09/1999CA2333964A1 Aza-heterocyclic compounds used to treat neurological disorders and hair loss
12/09/1999CA2333960A1 Ureas and carbamates of n-heterocyclic carboxylic acids and carboxylic acid isosteres
12/09/1999CA2333515A1 Cyanoiminoquinoxaline derivatives
12/09/1999CA2332957A1 Substituted 1-(4-aminophenyl)pyrazoles and their use as anti-inflammatory agents
12/09/1999CA2328291A1 Substituted indolinones, the preparation thereof and their use as pharmaceutical compositions
12/08/1999EP0961772A1 2,4-diaminopyrimidine compounds as anti-cancer agents
12/08/1999EP0961618A1 Novel compounds
12/08/1999EP0659177B1 4-oxo-azetidine-2-sulphonic acid amides and their salts, process for their production and their use
12/08/1999CN1237965A Quaternary nitrogen heteerocycles, method for their production and their use as pesticides
12/08/1999CN1237962A Pyrrolidinyl and pyrrolinyl ethylamine compounds as kappa agonists
12/08/1999CN1237961A Aminoguanidines and alkoxyguanidines as protease inhibitors
12/08/1999CN1047166C Improved process for making sulfonyl isocyanates
12/07/1999US5998665 Therapy for nervous system disorders
1 ... 492 493 494 495 496 497 498 499 500 501 502 503 504 505 506 507 508 509 510 511 512 ... 626